Krensavage Asset Management, LLC
Top Portfolio Positions
20 positions ·
$255,698,339 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
84,282 | $49,977,540 | 19.55% | |
| ENTA |
Enanta Pharmaceuticals Inc
Healthcare
|
2,866,138 | $36,199,322 | 14.16% | |
| JAZZ |
Jazz Pharmaceuticals plc
Healthcare
|
167,816 | $31,725,614 | 12.41% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
524,786 | $29,645,161 | 11.59% | |
| EXEL |
Exelixis, Inc.
Healthcare
|
415,693 | $17,829,072 | 6.97% | |
| SNY |
Sanofi
Healthcare
|
323,946 | $15,607,718 | 6.10% | |
| SUPN |
Supernus Pharmaceuticals, Inc.
Healthcare
|
280,681 | $14,508,400 | 5.67% | |
| INDV |
Indivior Pharmaceuticals, Inc.
Healthcare
|
339,532 | $10,348,935 | 4.05% | |
| RARE |
Ultragenyx Pharmaceutical Inc.
Healthcare
|
390,879 | $8,188,915 | 3.20% | |
| VNDA |
Vanda Pharmaceuticals Inc.
Healthcare
|
1,180,388 | $8,156,481 | 3.19% |
Portfolio Trend
25 quarters · across all stocks
Holdings in UTHR
Shares Held
Position Value (USD)
25 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $49,977,540 | 84,282 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $44,477,154 | 91,282 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $40,934,179 | 97,646 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $29,064,303 | 101,146 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $30,280,745 | 98,228 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $32,481,391 | 92,057 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $35,953,972 | 100,332 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $37,655,158 | 118,208 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $36,000,340 | 156,714 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $44,169,744 | 200,872 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $45,450,013 | 201,222 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $44,749,336 | 202,715 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $45,264,555 | 202,110 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $53,406,628 | 192,048 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $41,961,217 | 200,407 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $47,417,365 | 201,228 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $36,171,208 | 201,612 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $44,255,776 | 204,812 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $38,261,034 | 207,287 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $39,414,582 | 219,690 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $41,720,650 | 249,421 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $48,957,891 | 322,537 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $43,047,715 | 426,215 | Shares | Sole | 2020-12-08 | |
| 2020-06-30 | $57,178,308 | 472,548 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $51,174,630 | 539,646 | Shares | Sole | 2020-05-18 | |
| No 13F history on record for this holder in this stock. | ||||||